Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thoracic Radiotherapy Combined With EGFR-TKI for Wild-type NSCLC
NCT02738983Phase 2Unknown
- Start
- Jan 2012
- Primary completion
- Dec 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of erlotinib, icotinib in non-small cell lung cancer (NSCLC). Status: unknown.
02
Drugs
erlotinibicotinib
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT02738983.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02738983.